BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 17224655)

  • 21. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y; Harada H
    Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelodysplastic/myeloproliferative neoplasms.
    Hyjek E; Vardiman JW
    Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
    Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
    Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric myelodysplastic syndromes.
    Rytting ME
    Curr Hematol Rep; 2004 May; 3(3):173-7. PubMed ID: 15087064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment of juvenile myelomonocytic leukemia(JMML)].
    Adachi S; Nakahata T
    Nihon Rinsho; 2001 Dec; 59(12):2401-6. PubMed ID: 11766346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What to improve in approach to diagnose and treat pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia in Poland?].
    Wójcik D; Pietras W; Ussowicz M; Chybicka A
    Przegl Lek; 2006; 63(1):29-30. PubMed ID: 16892896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of chronic myeloid disorders: from Dameshek towards a semi-molecular system.
    Tefferi A; Gilliland G
    Best Pract Res Clin Haematol; 2006; 19(3):365-85. PubMed ID: 16781478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leukemias in advanced age. Part 2: Myelodysplastic syndrome and chronic leukemia].
    Jehn U
    Fortschr Med; 1994 May; 112(13):180-4. PubMed ID: 8020858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The WHO classification of the myelodysplastic syndromes.
    Bain B
    Exp Oncol; 2004 Sep; 26(3):166-9. PubMed ID: 15494682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of the chronic leukemias: special considerations in the elderly patient. Part III rarer chronic myeloid leukemias.
    Spiers AS
    Hematology; 2002 Feb; 7(1):1-8. PubMed ID: 12171771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.
    Dirnhofer S; Went P; Tichelli A
    Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
    Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings.
    Brandwein JM; Horsman DE; Eaves AC; Eaves CJ; Massing BG; Wadsworth LD; Rogers PC; Kalousek DK
    Am J Pediatr Hematol Oncol; 1990; 12(1):63-70. PubMed ID: 2309981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
    Lasky J; Sakamoto KM
    MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
    [No Abstract]   [Full Text] [Related]  

  • 35. Myelodysplastic syndrome in children and adolescents.
    Niemeyer CM; Baumann I
    Semin Hematol; 2008 Jan; 45(1):60-70. PubMed ID: 18179970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.
    Phekoo KJ; Richards MA; Møller H; Schey SA;
    Haematologica; 2006 Oct; 91(10):1400-4. PubMed ID: 17018393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical chronic myeloid leukemias.
    Oscier D
    Pathol Biol (Paris); 1997 Sep; 45(7):587-93. PubMed ID: 9404484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in biological and therapeutic aspects of myeloproliferative disorders.
    Mancini M; Diverio D; Alimena G; Mandelli F
    Curr Opin Hematol; 1994 Jul; 1(4):261-7. PubMed ID: 9371292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.